rs201241191
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM1BP4_StrongBP6
The NM_000146.4(FTL):c.169G>A(p.Glu57Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,614,072 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000146.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FTL | NM_000146.4 | c.169G>A | p.Glu57Lys | missense_variant | 2/4 | ENST00000331825.11 | NP_000137.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FTL | ENST00000331825.11 | c.169G>A | p.Glu57Lys | missense_variant | 2/4 | 1 | NM_000146.4 | ENSP00000366525 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152224Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251376Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135892
GnomAD4 exome AF: 0.000105 AC: 153AN: 1461848Hom.: 1 Cov.: 33 AF XY: 0.000128 AC XY: 93AN XY: 727230
GnomAD4 genome AF: 0.000158 AC: 24AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74370
ClinVar
Submissions by phenotype
sporadic abdominal aortic aneurysm Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | TilsonLab, Columbia University | Sep 21, 2014 | Observed frequency of 48965836(G>A) in 2/19 patients with abdominal aortic aneurysm versus heterozygosity described in "Variation Viewer" as 0.0002. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 12, 2023 | Variant summary: FTL c.169G>A (p.Glu57Lys) results in a conservative amino acid change located in the Ferritin/DPS protein domain (IPR008331) of the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00018 in 251376 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.169G>A in individuals affected with L-Ferritin Deficiency and no experimental evidence demonstrating its impact on protein function have been reported. Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
FTL-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 16, 2024 | The FTL c.169G>A variant is predicted to result in the amino acid substitution p.Glu57Lys. This variant has been reported in two individuals with abdominal aortic aneurysm; however, no additional evidence was provided to support pathogenicity (Tilson et al. 2006. PubMed ID: 17182944). In ClinVar, this variant has conflicting interpretations of benign, likely benign, and likely pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/156439/). This variant is reported in 0.41% of alleles in individuals of Ashkenazi Jewish descent in gnomAD, which is high for a dominant pathogenic variant. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Hereditary hyperferritinemia with congenital cataracts Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Hereditary hyperferritinemia with congenital cataracts;C1853578:Neuroferritinopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 03, 2023 | - - |
Neuroferritinopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2019 | Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at